Relay Therapeutics, Inc. RLAY Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s cash ratio?
- Relay Therapeutics, Inc. (RLAY) reported cash ratio of 6.9× in Q1 2026.
- How has Relay Therapeutics, Inc.'s cash ratio changed year-over-year?
- Relay Therapeutics, Inc.'s cash ratio increased by 172.4% year-over-year, from 2.5× to 6.9×.
- What is the long-term trend for Relay Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s cash ratio has grown at a -36.9% compound annual growth rate (CAGR), from 32.8× to 3.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.